Try our beta test site
1884 studies found for:    Blood Coagulation Disorders: Clinical Trials
Show Display Options
Rank Status Study
21 Completed A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
22 Completed Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Interventions: Drug: Concizumab;   Drug: placebo
23 Completed
Has Results
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Condition: HIV-1 Infection
Interventions: Drug: atorvastatin;   Drug: placebo for atorvastin
24 Completed
Has Results
Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725
Conditions: Congenital Bleeding Disorder;   Congenital FXIII Deficiency
Intervention: Drug: catridecacog
25 Completed Evaluation of the TICCS Capacity to Identify Trauma Patients With Acute Coagulopathy and Massive Bleeding
Conditions: Multiple Trauma;   Massive Bleeding;   Early Complication of Trauma
Intervention:
26 Completed Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
Conditions: Coronary Heart Disease;   Coagulation Disorder
Intervention: Drug: Anfibatide
27 Recruiting Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
28 Unknown  Study Using Plasma for Patients Requiring Emergency Surgery
Conditions: Hemorrhagic Shock;   Blood Coagulation Disorders;   Blood Products;   Trauma;   Ruptured AAA
Intervention: Drug: Human Plasma
29 Completed Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.
Conditions: Blood Coagulation Disorders;   Hemorrhage
Intervention: Drug: Human fibrinogen concentrate
30 Terminated
Has Results
Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding
Conditions: Acquired Bleeding Disorder;   Trauma
Interventions: Drug: eptacog alfa (activated);   Drug: placebo
31 Completed Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Haemophilia B
Intervention: Drug: activated recombinant human factor VII
32 Terminated A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects
Conditions: Congenital Bleeding Disorder;   Haemophilia A;   Healthy
Intervention: Drug: NNC172-2021
33 Completed Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: nonacog beta pegol
34 Recruiting Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: nonacog beta pegol
35 Withdrawn Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma
Conditions: Acquired Bleeding Disorder;   Trauma
Intervention: Drug: activated recombinant human factor VII
36 Not yet recruiting Management of Coagulopathy in Cirrhotic Patients Undergoing Invasive Procedures
Conditions: Liver Cirrhosis;   Coagulopathy
Intervention: Other: Thromboelastography based protocol
37 Completed Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients
Conditions: Trauma;   Coagulopathy
Interventions: Drug: Freezed-dried plasma;   Drug: Fresh-frozen plasma
38 Completed Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever
Conditions: Acquired Bleeding Disorder;   Dengue Haemorrhagic Fever
Interventions: Drug: activated recombinant human factor VII;   Drug: placebo
39 Completed Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Conditions: Congenital Bleeding Disorder;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors
Intervention: Other: No treatment given
40 Completed
Has Results
Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
Conditions: Congenital Bleeding Disorder;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors
Interventions: Drug: vatreptacog alfa (activated);   Drug: eptacog alfa (activated)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.